Treatment with 600 mg ALA daily improved MMSE scores in mild to moderate AD patients particularly if there was a comorbidity with type-2-diabetes [585], perhaps due to the additional capability of ALA of improving insulin sensitivity. The gene discussed is INS; the disease is Alzheimer disease.